Skip to content

Revvity RVTY Restructuring Charges

Restructuring Charges at other companies

IQVIA logo
IQVIAIQV
$51M+75.9%
STERIS logo
STERISSTE
$0-100%
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC
Zoetis logo
ZoetisZTS

Segments

By segment

See full
Diagnostics$7.55M+5,496%
Life Sciences$3.23M+27.7%

Other financials

Income statement

See full
Revenue$711.1M+7.0%
Gross profit$387.7M+3.2%
Operating income$75.9M+5.1%
Net income$40.7M-3.6%
EPS (diluted)$0.36+2.9%

Balance sheet

See full
Cash & equivalents$861.5M-24.3%
Total debt$3.9B+17.8%
Total equity$7.2B-5.9%
Total assets$12.0B-2.9%

Cash flow

See full
Operating cash flow$115.2M-10.1%
CapEx$19.8M+23.7%
Free cash flow$95.5M-14.9%

Valuation

See full
Market cap$11.16B-22.9%
Enterprise value$14.24B-13.7%
P/E46.5×-4.0×
P/S3.8×-1.4×

Profitability

See full
Gross margin48.5%
Operating margin12.4%-1.1pp
Net margin8.3%-2.1pp
FCF margin17%-1.9pp

Returns & leverage

See full
Return on equity3.2%-0.5pp
Debt / equity0.5×+0.1×
Current ratio1.7×-1.9×

Where this comes from

Reported directly by Revvity in its filing.

Tagged under the XBRL concept us-gaap:RestructuringCosts.

The official record: Revvity’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Revvity's restructuring charges.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Revvity's restructuring charges?
Revvity (RVTY) reported restructuring charges of $10.68M in Q1 2026.
How has Revvity's restructuring charges changed year-over-year?
Revvity's restructuring charges increased by 229.6% year-over-year, from $3.24M to $10.68M.
What is the long-term trend for Revvity's restructuring charges?
Over 2 years (2021 to 2023), Revvity's restructuring charges has grown at a 130.1% compound annual growth rate (CAGR), from -$5.02M to $26.6M.